ÀǾàǰ ¹«±Õ ½ÃÇè ½ÃÀå : À¯Çüº°, Á¦Ç° À¯Çüº°, Å×½ºÆ® À¯Çüº°, »ùÇú°, ÃÖÁ¾ ¿ëµµº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2024-2032³â)
Pharmaceutical Sterility Testing Market, By Type, By Product Type, By Test Type, By Sample, By End-use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
»óǰÄÚµå : 1454103
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2024³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 299 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,516,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,462,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 7,852,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

º¸°í¼­ ÇÏÀ̶óÀÌÆ®

Á¦¾à ¹«±Õ ½ÃÇè ½ÃÀå ±Ô¸ð´Â 2023³â 14¾ï 5,654¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ 10.9% ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀǾàǰ ¹«±Õ ½ÃÇè ½ÃÀå - ½ÃÀå ¿ªÇÐ

¿¬±¸ °³¹ß ¹× ÀǾàǰ Ãâ½Ã Áõ°¡·Î ½ÃÀå ¼ö¿ä ÃËÁø

¿¬±¸°³¹ß(R&D) ÁöÃâ Áõ°¡¿Í ÀǾàǰ Ãâ½Ã Áõ°¡´Â ÀǾàǰ ¹«±Õ ½ÃÇè »ê¾÷ÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. ÀǾàǰ Á¦Á¶ °øÁ¤¿¡¼­ ¹«±ÕÀ» À¯ÁöÇÏ´Â °ÍÀº ¿À¿°À» ÇÇÇϰí ÀǾàǰ¿¡ »ì¾ÆÀÖ´Â ¹Ì»ý¹°ÀÌ Æ÷ÇÔµÇÁö ¾Êµµ·Ï º¸ÀåÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¸ñÇÒ ¸¸ÇÑ °ÍÀº ¿µ±¹ Á¤ºÎ°¡ 2022³â 3¿ù¿¡ »õ·Î¿î Ä¡·á¹ý°ú Àåºñ¸¦ °³¹ßÇϱâ À§ÇÑ ¿¬±¸°³¹ß ÇÁ·ÎÁ§Æ®¿¡ 3¾ï 4,700¸¸ ´Þ·¯ÀÇ ¸·´ëÇÑ ÀÚ±ÝÀ» ÅõÀÔÇÏ¿© Á¦¾à »ê¾÷ÀÇ ¹ßÀüÀ» ¾à¼ÓÇß´Ù´Â Á¡ÀÔ´Ï´Ù. ¶ÇÇÑ 2021³â 12¿ù IQVIAÀÇ Á¶»ç¿¡ µû¸£¸é ÇâÈÄ 5³â°£ ½ÅÁ¦Ç°¿¡ ´ëÇÑ ÁöÃâÀÌ ´«¿¡ ¶ç°Ô Áõ°¡Çϰí, ƯÈ÷ Àü¹® ÀǾàǰ, Æ´»õ ÀǾàǰ, Èñ±Í ÀǾàǰ Ä«Å×°í¸®¿¡¼­ ½Å¾à Ãâ½Ã°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù. ÀÌ¿Í °°ÀÌ ¾Õ¼­ ¾ð±ÞÇÑ »ç½ÇµéÀÌ ÀǾàǰ ¹«±Õ ½ÃÇè ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

ÀǾàǰ ¹«±Õ ½ÃÇè ½ÃÀå - ÁÖ¿ä ÀλçÀÌÆ®

¸®¼­Ä¡ ¾Ö³Î¸®½ºÆ®ÀÇ ºÐ¼®¿¡ µû¸£¸é, ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£(2024-2032³â) µ¿¾È ¿¬Æò±Õ ¾à 10.9%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Á¦Ç° À¯Çüº°·Î´Â ŰƮ ¹× ½Ã¾à ºÎ¹®ÀÌ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

»ùÇà ¼¼ºÐÈ­¿¡¼­ Á¦¾à ºÐ¾ß°¡ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù.

Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2023³â ¸ÅÃâÀ» ÁÖµµÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀǾàǰ ¹«±Õ ½ÃÇè ½ÃÀå - ¼¼ºÐÈ­ ºÐ¼® :

¼¼°è ÀǾàǰ ¹«±Õ ½ÃÇè ½ÃÀåÀº À¯Çü, Á¦Ç° À¯Çü, Å×½ºÆ® À¯Çü, »ùÇÃ, ÃÖÁ¾ ¿ëµµ ¹× Áö¿ªÀ» ±âÁØÀ¸·Î ¼¼ºÐÈ­µË´Ï´Ù.

½ÃÀåÀº Á¦Ç° À¯Çü¿¡ µû¶ó Àåºñ, ŰƮ ¹× ½Ã¾à, ¼­ºñ½º µî µÎ °¡Áö ¹üÁÖ·Î ³ª´¹´Ï´Ù. ŰƮ ¹× ½Ã¾à ºÎ¹®ÀÌ ½ÃÀåÀ» Áö¹èÇϰí ÀÖ½À´Ï´Ù. ÀÌ ºÎ¹®ÀÇ ¼ºÀåÀº ±â¼ú ¹ßÀü Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù.

½ÃÀåÀº Ç¥º»À» ±âÁØÀ¸·Î ÀÇ·á±â±â, ÀǾàǰ, Á¦¾à, ¹ÙÀÌ¿À ÀǾàǰ µî 4°³ ºÎ¹®À¸·Î ³ª´¹´Ï´Ù. ÀǾàǰ ºÐ¾ß°¡ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖÀ¸¸ç, ¿¹Ãø ±â°£ µ¿¾È¿¡µµ ±× ¿ìÀ§¸¦ À¯ÁöÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. Á¦¾à »ç¾÷Àº ¾ö°ÝÇÑ ±ÔÁ¦¸¦ ¹Þ°í Àֱ⠶§¹®¿¡ ¹«±Õ °Ë»ç´Â GMP(Good Manufacturing Practice)¿Í °°Àº ±ÔÁ¦ Ç¥ÁØÀ» ÁؼöÇϱâ À§ÇØ ÇʼöÀûÀÔ´Ï´Ù. Á¦¾à»ç´Â Àü¹® °Ë»ç ±â°ü¿¡ ¹«±Õ °Ë»ç¸¦ À§Å¹ÇÔÀ¸·Î½á Àü¹® ½Ã¼³°ú Àη¿¡ ¸¹Àº ºñ¿ëÀ» µéÀÌÁö ¾Ê°íµµ ÀÌ·¯ÇÑ ¾ö°ÝÇÑ ±ÔÁ¦ ±âÁØÀ» ´Þ¼ºÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀǾàǰ¿¡´Â ¿¡¾î·ÎÁ¹, ¿¬°í, Á¡¾ÈÁ¦, ºñ°æ±¸ ¿ë¾× ¹× ±âŸ Á¦Çü µî ´Ù¾çÇÑ Á¦ÇüÀÌ Æ÷ÇԵ˴ϴÙ.

ÀǾàǰ ¹«±Õ ½ÃÇè ½ÃÀå - Áö¸®Àû ÅëÂû·Â

Áö¸®ÀûÀ¸·Î ÀÌ ½ÃÀåÀº ºÏ¹Ì, ¶óƾ¾Æ¸Þ¸®Ä«, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¿¡ °ÉÃÄ ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀº ºñÁî´Ï½º¸¦ °¡Á® ¿À´Â ±¹°¡¿¡ µû¶ó ´õ ¼¼ºÐÈ­µË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾È ºÏ¹Ì°¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ´Â ¹Ì±¹°ú ij³ª´Ù¿¡¼­ Á¦¾à ȸ»ç°¡ ±ÞÁõÇÏ°í ¿©·¯ ±â¾÷ÀÌ ½ÃÀå¿¡ ÁøÀÔÇϰí Àֱ⠶§¹®ÀÔ´Ï´Ù. ÀÌ ½ÃÀåÀÇ ¼ºÀåÀº ±â¼úÀûÀ¸·Î Á¤±³ÇÑ CRO ¹× CDMOÀÇ Á¸Àç¿Í º¸Á¶±Ý ºÐ¹è Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù. ÇâÈÄ ¿¹»ó ±â°£ µ¿¾È ´Ù¾çÇÑ Áúº´ÀÇ ºóµµ°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÀÓ»ó ¿¬±¸¿¡ ´õ ¸¹Àº ÀÚ±ÝÀÌ ÅõÀ﵃ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ÀǾàǰ °³¹ß ³ë·Â Áõ°¡, ±â¼ú Çõ½Å ¹× Àμö¿Í °°Àº Àü·«Àû ÀÌ´Ï¼ÅÆ¼ºê, »ý¸í °øÇÐ ¹× Á¦¾à ȸ»çÀÇ Á¸Àç, ÀÌ ºÐ¾ßÀÇ ÀÓ»ó ¿¬±¸ ¼ö Áõ°¡´Â ½ÃÀå È®´ëÀÇ Áß¿äÇÑ ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

ÀǾàǰ ¹«±Õ ½ÃÇè ½ÃÀå - °æÀï »óȲ:

ÀϺΠ´ë±â¾÷µéÀº ½ÃÀå ÁöÀ§¸¦ Çâ»ó½ÃŰ°í °í°´¿¡°Ô ´Ù¾çÇÑ ¼­ºñ½º¸¦ Á¦°øÇϱâ À§ÇØ Àü·«Àû ³ë·ÂÀ» ±â¿ïÀ̰í ÀÖ½À´Ï´Ù. ½ÃÀå¿¡¼­ÀÇ ÀÔÁö¿Í ¼öÀÍÀ» ³ôÀÌ°í °æÀï·ÂÀ» È®º¸Çϱâ À§ÇØ ±â¾÷µéÀº ÆÄÆ®³Ê½Ê, °è¾à, ÇÕÀÛ ÅõÀÚ, ¼­ºñ½º Ãâ½Ã ¹× ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ±âŸ Àü¼úÀ» ÀÚÁÖ È°¿ëÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÀǾàǰ ¹«±Õ ½ÃÇè ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ÀǾàǰ ¹«±Õ ½ÃÇè ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå ÀǾàǰ ¹«±Õ ½ÃÇè ¾÷°è Á¶»ç

Á¦5Àå ÀǾàǰ ¹«±Õ ½ÃÇè ½ÃÀå : COVID-19ÀÇ ¿µÇ⠺м®

Á¦6Àå ÀǾàǰ ¹«±Õ ½ÃÇè ½ÃÀå ±¸µµ

Á¦7Àå ÀǾàǰ ¹«±Õ ½ÃÇè ½ÃÀå - À¯Çüº°

Á¦8Àå ÀǾàǰ ¹«±Õ ½ÃÇè ½ÃÀå - Á¦Ç° À¯Çüº°

Á¦9Àå ÀǾàǰ ¹«±Õ ½ÃÇè ½ÃÀå - ½ÃÇè À¯Çüº°

Á¦10Àå ÀǾàǰ ¹«±Õ ½ÃÇè ½ÃÀå - »ùÇú°

Á¦11Àå ÀǾàǰ ¹«±Õ ½ÃÇè ½ÃÀå - ÃÖÁ¾ ¿ëµµº°

Á¦12Àå ÀǾàǰ ¹«±Õ ½ÃÇè ½ÃÀå - Áö¿ªº°

Á¦13Àå ÁÖ¿ä º¥´õ ºÐ¼® - ÀǾàǰ ¹«±Õ ½ÃÇè ¾÷°è

Á¦14Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

Pharmaceutical Sterility Testing Market size was valued at USD 1,456.54 Million in 2023, expanding at a CAGR of 10.9% from 2024 to 2032.

Sterility testing is a method that determines whether or not live bacteria exist in a medicinal product. The purpose is to guarantee that the product fulfils sterility criteria, therefore reducing the danger of microbiological contamination that might endanger patient safety.

Pharmaceutical Sterility Testing Market- Market Dynamics

Increasing R&D and drug launches to propel market demand

Increased expenditure in research and development (R&D) and a rise in medication launches are the main factors driving growth in the pharmaceutical sterility testing industry. Preserving sterility during the drug-making process is essential to avoid contamination and guarantee that the drugs don't contain living microbes. Notably, the UK government committed to developing the pharmaceutical industry in March 2022 by pledging a sizeable $347 million for research and development projects aimed at creating novel therapies and instruments. In addition, IQVIA's research from December 2021 predicts a notable increase in expenditure on new products over the next five years, along with an increase in the launch of new pharmaceuticals, especially in the specialty, niche, and orphan drug categories. Thus, the aforementioned facts drive the pharmaceutical sterility testing market.

Pharmaceutical Sterility Testing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.9% over the forecast period (2024-2032)

Based on product type segmentation, the Kits & Reagents segment dominates the market

Based on sample segmentation, the pharmaceuticals sector dominates the market

Based on region, North America was the leading revenue generator in 2023

Pharmaceutical Sterility Testing Market- Segmentation Analysis:

The Global Pharmaceutical Sterility Testing Market is segmented based on Type, Product Type, Test Type, Sample, End-use, and Region.

The market is divided into two categories based on product type: Instruments, Kits & Reagents and Services. The Kits & Reagents segment dominates the market. The segment growth is attributed to the increasing technological advancements.

The market is divided into four categories based on sample: Medical Devices, Pharmaceuticals and Biopharmaceuticals. The Pharmaceuticals sector dominates the market and is likely to maintain its dominance during the forecast period. Sterile testing is essential to guarantee adherence to regulatory standards like Good Manufacturing Practices (GMP), as the pharmaceutical business is subject to stringent regulatory regulations. Pharmaceutical businesses can achieve these strict regulatory criteria without incurring significant costs for specialist facilities and staff by outsourcing sterility testing to specialized laboratories. Pharmaceuticals include a wide range of dosage forms, including aerosols, ointments, eye drops, parenteral solutions, and other formulations.

Pharmaceutical Sterility Testing Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to hold the largest market share over the forecast period. This is explained by the proliferation of pharmaceutical businesses and the existence of several significant market participants in the United States and Canada. The market's growth can be attributed to the presence of technologically sophisticated CROs and CDMOs as well as an increase in grant distribution. Over the anticipated timeframe, additional funds would be invested in clinical research due to the rising frequency of various diseases. In addition, increased efforts toward medication development, strategic initiatives such as innovation and acquisitions, the existence of biotech and pharmaceutical companies, and an increase in the number of clinical studies in the area are important drivers of market expansion.

Pharmaceutical Sterility Testing Market- Competitive Landscape:

Several major businesses are implementing some strategic efforts to improve their market position and provide a wide range of services to customers. To boost market presence and revenue and obtain a competitive edge, organizations frequently engage in partnerships and agreements, joint ventures, service launches, and other tactics that fuel market growth.

Recent Developments:

In May 2023, Thermo Fisher Scientific, Inc. declared the opening of a Singaporean sterile pharmaceuticals factory. It would assist in supplying the Asia Pacific market with novel vaccinations and medications.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Sotera Health Company (Nelson Labs)

Boston Analytical

Steris Plc

Pacific Biolabs

Sartorius Ag

Solvias Ag

SGS SA

Pace Analytical

Labcorp

Thermo Fisher Scientific, Inc.

Charles River Laboratories

Almac Group

Rapid Micro Biosystems, Inc.

Labor LS SE & Co. KG

GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET, BY SAMPLE- MARKET ANALYSIS, 2019 - 2032

GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032

GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

Table of Contents

1.Pharmaceutical Sterility Testing Market Overview

2.Executive Summary

3.Pharmaceutical Sterility Testing Key Market Trends

4.Pharmaceutical Sterility Testing Industry Study

5.Pharmaceutical Sterility Testing Market: COVID-19 Impact Analysis

6.Pharmaceutical Sterility Testing Market Landscape

7.Pharmaceutical Sterility Testing Market - By Type

8.Pharmaceutical Sterility Testing Market - By Product Type

9.Pharmaceutical Sterility Testing Market - By Test Type

10.Pharmaceutical Sterility Testing Market - By Sample

11.Pharmaceutical Sterility Testing Market - By End-use

12.Pharmaceutical Sterility Testing Market- By Geography

13.Key Vendor Analysis- Pharmaceutical Sterility Testing Industry

14.360 Degree Analyst View

15.Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â